Financial, market and economic news

: Pfizer could know if COVID-19 vaccine candidate is effective by end of October

Shares of Pfizer Inc. rallied to a 7-week high Friday, after the drug maker said it is on track to know whether its potential COVID-19 vaccine is effective by the end of October, and currently expects to apply for Emergency Use Authorization by the second half of November.

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy